Neutropenic enterocolitis in a patient with ovarian cancer after treatment with high-dose carboplatin and granulocyte macrophage-colony stimulating factor (GM-CSF)

Neth J Med. 1990 Oct;37(3-4):158-61.

Abstract

A 50-yr-old women is described with relapsed ovarian cancer. She developed neutropenic enterocolitis after treatment with high-dose carboplatin (1000 mg/m2) and granulocyte macrophage-colony stimulating factor (GM-CSF). The clinical features and the pathogenesis of neutropenic enterocolitis are discussed. This case is the first report of neutropenic enterocolitis associated with the treatment of carboplatin.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Carboplatin / administration & dosage
  • Combined Modality Therapy
  • Enterocolitis / chemically induced*
  • Female
  • Humans
  • Macrophage Colony-Stimulating Factor / administration & dosage
  • Middle Aged
  • Neutropenia / chemically induced*
  • Ovarian Neoplasms / drug therapy*

Substances

  • Macrophage Colony-Stimulating Factor
  • Carboplatin